CVS Caremark to pay $95M in Medicare fraud case A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs.

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it continues to struggle with recent challenges, an analyst said.

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that ...

A U.S. federal judge has ordered CVS Caremark, the pharmacy benefits arm of CVS Health, to pay $95 million over allegations it overbilled Medicare for prescription drugs. The decision was made by ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. A former Aetna actuary in the Medicare department won a $95 million False Claims Act judgment (PDF) against ...

CVS Caremark to pay $95M in Medicare fraud case. Sydney Halleman . Thu, Jun 26, 2025, 5:16 AM 2 min read. In This Article: CVS . This story was originally published on Healthcare Dive.

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.